In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, accessible and inexpensive than other existing tests. When you purchase through ...
London-based patient engagement firm iPLATO Healthcare has been acquired by global healthtech firm Huma. iPLATO’s software covers a network of 26.6 million patients across nearly 3,000 NHS primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results